This document summarizes a presentation given at the WCPT Conference in Amsterdam on cervical spine health and manipulation. The presentation addressed several questions: whether osteopathic manipulative therapy (OMT) can cause cervical artery dissection (CAD), how chiropractic compares to OMT, what the risk factors and signs/symptoms of CAD are, and what should be included in consent discussions given the uncertainty of risks and potentially equivocal benefits of cervical mobilization. The presentation discussed contraindications and cautions for cervical manipulation and reviewed studies on risk of vertebrobasilar artery stroke associated with chiropractic manipulation.
Prostate Cancer: International Consultation on Prostate Cancer (Role: Public...calbino74
International consultations are an important collaborative initiative between the SIU and the International Consultation on Urologic Disease (ICUD). These annual joint consultations involve numerous international experts grouped into working committees that focus on specific aspects of the consultation topic.
Their conclusions are presented during the SIU Congress, and later published in a comprehensive volume that becomes a valuable international reference on the topic.
Prostate Cancer: International Consultation on Prostate Cancer (Role: Public...calbino74
International consultations are an important collaborative initiative between the SIU and the International Consultation on Urologic Disease (ICUD). These annual joint consultations involve numerous international experts grouped into working committees that focus on specific aspects of the consultation topic.
Their conclusions are presented during the SIU Congress, and later published in a comprehensive volume that becomes a valuable international reference on the topic.
Does OMPT cause CAD?
“Lack of Evidence but possibly ~ 1.3 / 100,000 patients”
What are the risk factors for CAD?
“Many including SMT- more in the young”
What are the signs and symptoms?
“Headache, “5DA3N”, Cranial Nerves, UC Instability”
What should be included in consent discussions?
“Worst case, Small odds, Uncertainty, Alternatives”
Highly malignant tumor of mesenchymal origin.Spindle shaped cells that produce osteoid.2nd most common primary malignant bone tumor after MM.Incidence – 1 to 3 per million per year
Treated by chemo,amputation or rotationplasty
Microvascular & Functional Ultrasound Imaging: Insights into Stroke and Neuro...InsideScientific
Professors Franck Lebrin and Denis Vivien discuss in vivo molecular and functional imaging, including ultrasound-based markers, and their application to the study and treatment of neurological disorders such as cerebral hereditary angiopathies and stroke.
Early vascular dysfunction is increasingly recognized as the underlying cause of many neurological diseases. The development of drugs targeting vascular damage at its earliest stages could therefore pave the road towards the treatment of neurological disorders. However, to be effective, this therapeutic approach will require the identification of early markers of vascular injury.
In the first portion of the webinar, Prof. Lebrin discusses his research on ultrasound markers of early vascular dysfunction in cerebral hereditary angiopathies (CHA) and the testing of novel therapeutic agents that restore vascular function. Albeit rare, blood vessels from CHA exhibit the salient features of other neurological diseases and as such provide tractable preclinical models for research and defined patient groups for trials. Prof. Lebrin expects to identify early cerebrovascular markers that could ultimately be translated to the clinic for monitoring of disease progression and drug action.
In the second portion of the webinar, Prof. Vivien presents current therapeutic approaches for ischemic stroke intended to restore cerebral blood flow (CBF) as quickly and efficiently as possible, including rtPA treatment (tissue type Plasminogen Activator) and endovascular thrombectomy (EVT). Prof. Vivien’s research aims to better understand the spatiotemporal evolution of specific functional and molecular events that occur during and following stroke, using a unique combination of in vivo high-resolution functional ultrafast ultrasound imaging (HR-fUS) and high-resolution molecular magnetic resonance imaging (HRmol-MRI). This project has led to the proposal of an innovative platform to test future therapeutics of ischemic stroke with a greater chance of successful translation to the clinic.
Summary of Composite Tissue Graft section of 2011 Paris Banff meetingKim Solez ,
Dr. Linda Cendales meeting summary of composite tissue graft section of 2011 Eleventh Banff Conference on Allograft Pathology, June 6-10, 2011 in Paris, France.
Robotic spine surgery is on the cutting edge of medicine, allowing our surgeons to exercise an incredible level of precision, well beyond standard capabilities.
Does OMPT cause CAD?
“Lack of Evidence but possibly ~ 1.3 / 100,000 patients”
What are the risk factors for CAD?
“Many including SMT- more in the young”
What are the signs and symptoms?
“Headache, “5DA3N”, Cranial Nerves, UC Instability”
What should be included in consent discussions?
“Worst case, Small odds, Uncertainty, Alternatives”
Highly malignant tumor of mesenchymal origin.Spindle shaped cells that produce osteoid.2nd most common primary malignant bone tumor after MM.Incidence – 1 to 3 per million per year
Treated by chemo,amputation or rotationplasty
Microvascular & Functional Ultrasound Imaging: Insights into Stroke and Neuro...InsideScientific
Professors Franck Lebrin and Denis Vivien discuss in vivo molecular and functional imaging, including ultrasound-based markers, and their application to the study and treatment of neurological disorders such as cerebral hereditary angiopathies and stroke.
Early vascular dysfunction is increasingly recognized as the underlying cause of many neurological diseases. The development of drugs targeting vascular damage at its earliest stages could therefore pave the road towards the treatment of neurological disorders. However, to be effective, this therapeutic approach will require the identification of early markers of vascular injury.
In the first portion of the webinar, Prof. Lebrin discusses his research on ultrasound markers of early vascular dysfunction in cerebral hereditary angiopathies (CHA) and the testing of novel therapeutic agents that restore vascular function. Albeit rare, blood vessels from CHA exhibit the salient features of other neurological diseases and as such provide tractable preclinical models for research and defined patient groups for trials. Prof. Lebrin expects to identify early cerebrovascular markers that could ultimately be translated to the clinic for monitoring of disease progression and drug action.
In the second portion of the webinar, Prof. Vivien presents current therapeutic approaches for ischemic stroke intended to restore cerebral blood flow (CBF) as quickly and efficiently as possible, including rtPA treatment (tissue type Plasminogen Activator) and endovascular thrombectomy (EVT). Prof. Vivien’s research aims to better understand the spatiotemporal evolution of specific functional and molecular events that occur during and following stroke, using a unique combination of in vivo high-resolution functional ultrafast ultrasound imaging (HR-fUS) and high-resolution molecular magnetic resonance imaging (HRmol-MRI). This project has led to the proposal of an innovative platform to test future therapeutics of ischemic stroke with a greater chance of successful translation to the clinic.
Summary of Composite Tissue Graft section of 2011 Paris Banff meetingKim Solez ,
Dr. Linda Cendales meeting summary of composite tissue graft section of 2011 Eleventh Banff Conference on Allograft Pathology, June 6-10, 2011 in Paris, France.
Robotic spine surgery is on the cutting edge of medicine, allowing our surgeons to exercise an incredible level of precision, well beyond standard capabilities.
1. WCPT Conference, Amsterdam
Spinal Manipulation – Evidence for
Physiotherapist Delivery of Effective
Procedures – a focussed symposia
Duncan Reid DHSc – Convenor (New Zealand)
Tim Flynn PhD (USA)
Wayne Hing PhD (NZ)
Chris McCarthy PhD (UK)
Peiter Westerhuis (Switzerland)
2. Dr Chris McCarthy PhD, MCSP, FMACP
CERVICAL SPINE - GENERAL HEALTH
ASSESSMENT
WCPT Conference, Amsterdam
20 – 23 June 2011
3. Cervical Spine Health &
Manipulation
Does OMPT cause CAD?
What are the risk factors for CAD?
What are the signs and symptoms?
What should be included in consent
discussions?
WCPT Conference, Amsterdam
20 – 23 June 2011
5. Contraindications Cautions
Multilevel radiculopathy Local Infection
Worsening neurological function Inflammatory disease
Upper motor neuron lesion Active Cancer
Unremitting, severe, non-mechanical History of cancer
pain Long term steroid use (<3/12)
Fracture Osteoporosis
Symptoms of a Cervical Artery Dissection Systemically unwell
Symptoms of Cervical Instability Hypermobility syndrome
Connective tissue disease
Risk Factors for Cervical Artery
Moore et al. 2005 CSP Guidelines for Whiplash Dysfunction
Risk factors for Cervical Instability
WCPT Conference, Amsterdam
20 – 23 June 2011
7. •Young (45 years) vertebrobasilar artery territory stroke patients were 5 times more
likely than controls to have visited a chiropractor within 1 week of the event date.
•No significant associations were found for those aged 45 years.
•The best available estimate of the incidence,, states that for every 100,000 persons
45 years of age who receive CMT, approximately 1.3 cases of vertebral artery
dissection or occlusion attributable to CMT would be observed within 1 week of
manipulative therapy. WCPT Conference, Amsterdam
20 – 23 June 2011